BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
BIOXYTRAN, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026
- Market cap
- $2.56M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
–FY2025